Course: Lipoprotein metabolism--physiological and clinical aspects. Role of cholesterol and triglyceride determination in the prevention of metabolic diseases and the control of preventive measures
Rywik, S.
Przeglad Lekarski 34(3): 369-370
1977
ISSN/ISBN: 0033-2240 PMID: 866730 Document Number: 116556
Document emailed within 1 workday
Related Documents
Yoshino, G.; Hirano, T.; Kazumi, T. 1999: New clinical application of direct and chemical measurement of low density lipoprotein cholesterol-estimation of compositional changes in triglyceride-rich lipoprotein fraction Nihon Rinsho. Japanese Journal of Clinical Medicine 57(12): 2745-2753Vijayammal, P.L.; Leelamma, S.; Premakumari, K.; Kurup, P.A. 1982: Effect of composition of diet on some aspects of cholesterol and triglyceride metabolism in rats Indian Journal of Medical Research 75: 868-875
Beheshti, I.; Wessels, L.M.; Eckfeldt, J.H. 1994: EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods Clinical Chemistry 40(11 Pt 1): 2088-2092
Saku, K.; Okamoto, T.; Takeda, Y.; Jimi, S.; Zhang, B.; Bai, H.; Liu, R.; Arakawa, K. 1996: Short-term effects of a high-sucrose diet on plasma lipid, lipoprotein cholesterol, tissue lipoprotein lipase and hepatic triglyceride lipase in rats Artery 22(1): 36-48
Bruckert, E.; Giral, P.; Dairou, F.; De Gennes, J.L. 1988: High-density cholesterol lipoprotein: metabolism and role in atherosclerosis Presse Medicale 17(17): 862-866
Nadolski, H.; Stegemann, K.; Preissig, A.B. 1996: The need for preventive measures. Need for preventive measures at any price? Attempt at an argument in favor of the need for prevention not only for economic reasons Gesundheitswesen ) 58(8-9): 432-441
Wilson, P.W.; Abbott, R.D.; Garrison, R.J.; Castelli, W.P. 1981: Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma Clinical Chemistry 27(12): 2008-2010
Chwistecki, K.; Mrukowicz, M.; Bochenek, W.; Morgenstern, W.; Słowińska, R.; Rotter, A.; Pikiewicz, K. 1985: Triglyceride and low-density lipoprotein cholesterol (LDL-C) levels in a population of men aged 35-54 years from 8 industrial plants in Wrocław Przeglad Lekarski 42(6): 539-543
Sato, I.; Hyakuta, M.; Hayashi, F.; Mukai, M.; Kondo, S.; Maeda, E.; Kumagai, S. 2002: Usefulness of examination of the cholesterol versus triglyceride ratio for lipoprotein fractions in a patient with marked hyper-triglyceridemia Rinsho Byori. Japanese Journal of Clinical Pathology 50(10): 987-991
Whitmore, L.; Trejos, A.; Mata, L. 1986: Serum cholesterol, triglyceride, and high-density-lipoprotein concentrations in men with different dietary and exercise regimens in Puriscal, Costa Rica Archivos Latinoamericanos de Nutricion 36(2): 237-246
Fruchart, J.C.; Ailhaud, G. 1992: Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance Clinical Chemistry 38(6): 793-797
Kanep, V.V.; Kadnikova, G.I.; Baron, L.H.; Melnikova, L.P. 1989: Stomatological component of the integrated program for the prevention of non-infectious chronic diseases in the Latvian S.S.R. 2. Experience in the application of preventive measures against dental caries and periodontal diseases in children of the Latvian S.S.R La Sante Publique 32(3): 279-286
Nitiyanant, W.; Ploybutr, S.; Wasuwat, S.; Tandhanand, S. 1987: Effect of the dried powder extract, water soluble of garlic (Allium sativum) on cholesterol, triglyceride and high density lipoprotein in the blood Journal of the Medical Association of Thailand 70(11): 646-648
Weber, M.; McNicoll, S.; Marcil, M.; Connelly, P.; Lussier-Cacan, S.; Davignon, J.; Latour, Y.; Genest, J. 1997: Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians Canadian Journal of Cardiology 13(3): 253-260
Miyake, N.; Miyake, K.; Higurashi, H.; Ohsaka, A. 2007: Preheparin lipoprotein lipase mass and apolipoproteinC-IIi ratio helps identify postprandial triglyceride metabolic marker Rinsho Byori. Japanese Journal of Clinical Pathology 55(11): 1019-1024
Oida, K.; Nakai, T.; Tamai, T.; Kutsumi, Y.; Kobayashi, T.; Hayashi, T.; Yamada, S.; Takeda, R. 1982: Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia Artery 10(4): 266-285
Terao, T.; Miyoshi, M.; Yoshioka, T.; Nakano, S. 1985: How does endogenous and exogenous cholesterol influence the lipoprotein metabolism. Effects of long-term endurance exercise, and accumulation of cholesterol ester on the aortic wall Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 47(3): 130-140
Tamachi, H.; Goto, Y. 1988: Progress in the study of lipoprotein metabolism and atherosclerosis: organ-specific characteristics of lipoprotein metabolic disorders--with special reference to the heart and brain Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 671-678
Rindert de Vries; Borggreve, S.E.; Robin P. F. Dullaart 2003: Role of Lipases, Lecithin: Cholesterol Acyltransferase and Cholesteryl Ester Transfer Protein in Abnormal High Density Lipoprotein Metabolism in Insulin Resistance and Type 2 Diabetes Mellitus Clinical Laboratory 49(11-12): 601-613
Suchkova, S.N.; Afonina, I.P.; Titov, V.N.; Zadoia, A.A. 1977: Methodological problems of determination of cholesterol and triglyceride concentrations in blood plasma Laboratornoe Delo 6: 334-338